Open AccessA survey on the experience of 136 Italian urologists in the treatment of erectile dysfunction with PDE5 inhibitors and recommendations for the use of Avanafil in the clinical practice
Author(s) -
Vincenzo Mirone,
Ferdinando Fusco,
Fabio Parazzini,
Alessandro Zucchi
Publication year - 2016
Publication title -
archivio italiano di urologia andrologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.429
H-Index - 23
eISSN - 2282-4197
pISSN - 1124-3562
DOI - 10.4081/aiua.2016.2.128
Subject(s) - medicine , erectile dysfunction , tolerability , dosing , clinical practice , pharmacology , family medicine , adverse effect
PDE5 inhibitors are the firstline treatment for erectile dysfunction. Although all these drugs share the same mechanism of action, each agent could have different characteristics in terms of selectivity, pharmacokinetics and tolerability profile.